StemCell Institute Inc. (7096.T)
JPY 1286.0
(-7.28%)
JPY 1286.0
(-7.28%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 1.16 Billion JPY | 11.93% |
| 2022 | 1.03 Billion JPY | 17.41% |
| 2021 | 884.3 Million JPY | 5.61% |
| 2020 | 837.32 Million JPY | 11.49% |
| 2019 | 751 Million JPY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 316 Million JPY | 4.08% |
| 2023 Q2 | 283.39 Million JPY | -0.01% |
| 2023 Q4 | 303.62 Million JPY | 4.09% |
| 2023 Q3 | 291.69 Million JPY | 2.93% |
| 2023 FY | 1.16 Billion JPY | 11.93% |
| 2023 Q1 | 283.41 Million JPY | -2.1% |
| 2022 Q3 | 257.73 Million JPY | 2.11% |
| 2022 FY | 1.03 Billion JPY | 17.41% |
| 2022 Q4 | 289.5 Million JPY | 12.33% |
| 2022 Q2 | 252.4 Million JPY | 0.0% |
| 2021 FY | 884.3 Million JPY | 5.61% |
| 2020 FY | 837.32 Million JPY | 11.49% |
| 2019 FY | 751 Million JPY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 1.28 Billion JPY | 9.525% |
| PRISM BioLab Co.,LTD | 576.81 Million JPY | -101.472% |
| GNI Group Ltd. | 9.32 Billion JPY | 87.534% |
| Linical Co., Ltd. | 2.7 Billion JPY | 57.041% |
| Trans Genic Inc. | 2.15 Billion JPY | 46.194% |
| MEDINET Co., Ltd. | 1.49 Billion JPY | 22.066% |
| Soiken Holdings Inc. | 3.07 Billion JPY | 62.159% |
| Cytori Cell Research Institute, Inc. | 1.85 Billion JPY | 37.419% |
| AnGes, Inc. | 8.9 Billion JPY | 86.946% |
| OncoTherapy Science, Inc. | 943.08 Million JPY | -23.226% |
| Nxera Pharma Co., Ltd. | 19.19 Billion JPY | 93.944% |
| Immuno-Biological Laboratories Co., Ltd. | 412.99 Million JPY | -181.392% |
| NanoCarrier Co., Ltd. | 975.37 Million JPY | -19.147% |
| Carna Biosciences, Inc. | 2.56 Billion JPY | 54.739% |
| CanBas Co., Ltd. | 278 Million JPY | -318.029% |
| D. Western Therapeutics Institute, Inc. | 1.14 Billion JPY | -1.803% |
| RaQualia Pharma Inc. | 1.81 Billion JPY | 36.075% |
| Chiome Bioscience Inc. | 1.6 Billion JPY | 27.538% |
| Kidswell Bio Corporation | 2.37 Billion JPY | 51.049% |
| PeptiDream Inc. | 9.68 Billion JPY | 88.004% |
| Oncolys BioPharma Inc. | 1.96 Billion JPY | 40.726% |
| Ribomic Inc. | 1.1 Billion JPY | -5.104% |
| SanBio Company Limited | 4.53 Billion JPY | 74.397% |
| Healios K.K. | 3.48 Billion JPY | 66.673% |
| BrightPath Biotherapeutics Co., Ltd. | 1.15 Billion JPY | -0.639% |
| Kubota Pharmaceutical Holdings Co., Ltd. | 1.33 Billion JPY | 12.915% |
| Delta-Fly Pharma, Inc. | 1.4 Billion JPY | 17.196% |
| StemRIM | 2.07 Billion JPY | 44.021% |
| CellSource Co., Ltd. | 1.96 Billion JPY | 40.814% |
| FunPep Company Limited | 313.82 Million JPY | -270.314% |
| Kringle Pharma, Inc. | 958.01 Million JPY | -21.306% |
| Stella Pharma Corporation | 963.98 Million JPY | -20.554% |
| TMS Co., Ltd. | 943.25 Million JPY | -23.204% |
| Noile-Immune Biotech Inc. | 1.08 Billion JPY | -6.621% |
| Cuorips Inc. | 598.11 Million JPY | -94.296% |
| K Pharma,Inc. | 543.94 Million JPY | -113.648% |
| Takara Bio Inc. | 23.9 Billion JPY | 95.139% |
| ReproCELL Incorporated | 1.51 Billion JPY | 23.242% |
| PhoenixBio Co., Ltd. | 1.18 Billion JPY | 1.847% |
| Japan Tissue Engineering Co., Ltd. | 1.52 Billion JPY | 23.659% |
| CellSeed Inc. | 804.93 Million JPY | -44.375% |